2026 · 01
US trends in prescribing nonstatin lipid‑lowering therapy, 2019—2024.
Burka S, Dzaye O, Cao T, Mercer J, Jelwan Y, Nasir K, Banach M, Blaha MJ.
JAMA Cardiology.
doi:10.1001/jamacardio.2026.0844
2025 · 02
Erectile dysfunction and cardiovascular‑kidney‑metabolic syndrome: insights from All of Us.
Blazoski CM, Yao Z, Kohler TS, Miner MM, Mercer J, Blaha MJ.
American Journal of Preventive Cardiology, 24:101332.
doi:10.1016/j.ajpc.2025.101332
2025 · 03
Prevalence of clinical obesity versus BMI‑defined obesity among US adults.
Yao Z, Dardari ZA, Razavi AC, Mercer J, Benjamin EJ, Bhatnagar A, Blaha MJ.
The Lancet Diabetes & Endocrinology.
doi:10.1016/S2213-8587(25)00159-7
2025 · 04
Mercer J. E‑cigarette use and incident cardiometabolic conditions in All of Us.
Yao Z, Tasdighi E, Benjamin EJ, Bhatnagar A, Blaha MJ.
Nicotine & Tobacco Research, ntaf067.
doi:10.1093/ntr/ntaf067
2025 · 05
Mercer J. Association of e‑cigarette use, psychological distress, and substance use.
Yao Z, Tasdighi E, El Shahawy O, Benjamin EJ, Bhatnagar A, Blaha MJ.
Addictive Behaviors, 166:108322.
PMID: 40112576
2024 · 06
Mercer J, Khorsandi M, Blaha MJ. National and state estimates of SELECT trial eligibility.
JAMA Network Open, 7(7):e2420105.
2024 · 07
Mercer J, Boakye E, et al. Coronary artery calcium for stroke mortality prediction.
Vascular Medicine, 29(2):213—214.
doi:10.1177/1358863X231226217
2023 · 08
Mercer J, Boakye E, Obisesan O, et al. E‑cigarette use in the 2021 BRFSS Survey.
JAMA Network Open, 6(11):e2340859.
2023 · 09
Mercer J, Boakye E, Osuji N. Psychosocial stressors and e‑cigarette use in the YRBS.
BMC Public Health, 23(1).
2023 · 10
Mercer J, Boakye E, Osuji N. Tobacco product use and substance misuse among adolescents.
Preventive Medicine Reports, 33:102207.
2022 · 11
Boakye E, Osuji N, Mercer J. Patterns in e‑cigarette use among US adults, 2017—2020.
JAMA Network Open, 5(7):e2223266.
2022 · 12
Mirbolouk M, Boakye E, Mercer J, et al. E‑cigarette use among US high school students.
Preventive Medicine Reports, 29:101925.